AMA Announces 2023 Joy in Medicine Recognized Organizations
October 03, 2023 11:01 ET
|
American Medical Association
CHICAGO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today announced 72 health systems, hospitals and medical groups have earned national distinction as 2023 Joy in...
New Disappearing Doctors Campaign – “The Disposables” – Shines Light on Physicians Lost to Suicide
September 14, 2023 12:26 ET
|
IPG Health
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Ahead of National Physician Suicide Awareness Day on September 17, Disappearing Doctors – a global coalition of organizations founded by FCB Health New...
Doc2Doc Lending Ramps Up Growth and Expansion for the Rest of 2023
August 08, 2023 09:00 ET
|
Doc2Doc Lending
ATLANTA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Doc2Doc Lending, a personal lending platform designed specifically to meet the unique needs of physicians and dentists, today announced the results of its...
Apogee Announces First Participants Dosed Ahead of Schedule in Phase 1 Trial of APG777, its Novel Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
August 07, 2023 07:30 ET
|
Apogee Therapeutics, LLC
Preclinical data with APG777 demonstrate the potential for significantly improved dosing over standard of care, including the potential for every two- or three-month dosing Initial subcutaneous...
Apogee Therapeutics to Participate in Upcoming August Investor Conferences
August 02, 2023 07:30 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic...
Apogee Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 18, 2023 16:01 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic...
Apogee Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering
July 13, 2023 18:32 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic...
Evoke Pharma to Host First Key Opinion Leader Webinar on Healthcare Resource Utilization Data Related to Gastroparesis and its Treatment
June 14, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Physician Poll: Medical Misinformation Is Harming Patients' Health
March 29, 2023 00:24 ET
|
de Beaumont Foundation
Bethesda, Maryland, March 29, 2023 (GLOBE NEWSWIRE) -- In a new poll, nearly three in four physicians said medical misinformation has hindered their ability to treat COVID-19 patients and has harmed...
For Physicians, New Pathways to Concierge Medicine Continue to Unfold, Says Industry Pioneer
February 28, 2023 13:32 ET
|
Specialdocs Consultants
Chicago, IL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Concierge medicine, once considered care available for only a fortunate few, is experiencing a remarkable evolution as physician pathways to the model...